EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emergent radiotherapy for spinal cord compression/impingement—a narrative review

Peter Zaki, Andrew Barbour, Mark M Zaki, Yolanda D Tseng, Anubhav G Amin, Vyshak Venur, Tresa McGranahan, Balamurugan Vellayappan, Joshua D Palmer, Samuel T Chao, Jonathan T Yang, Matthew Foote und 5 weitere

Annals of Palliative Medicine · 2023

DOI: 10.21037/apm-23-342 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Palliative Medicine, 2023. Verfasst von Peter Zaki und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Spinal Cord Compression, Spinal Neoplasms, Radiosurgery. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Malignant epidural spinal cord compression (MESCC), often presenting with back pain and motor/sensory deficits, is associated with poor survival, particularly when there is loss of ambulation. The purpose of this review is to evaluate the literature and discuss appropriate workup and management of MESCC, specifically in the emergent setting. METHODS: A PubMed search was conducted on "spinal cord compression" and "radiation therapy." Articles were analyzed for the purpose of this narrative review. KEY CONTENT AND FINDINGS: If MESCC is suspected, neurologic examination and complete spine imaging are recommended. Emergent treatment is indicated if there is radiographic evidence of high-grade compression and/or clinically significant motor deficits. Treatment involves a combination of medical management, surgical decompression, radiation therapy (RT), and rehabilitation. For motor deficits, emergent initiation of high dose steroids is recommended. Circumferential surgical decompression ± stabilization followed by RT provides superior clinical outcomes than RT alone. For patients whom surgery is not reasonable, RT alone may provide significant treatment response which depends on radioresponsiveness of the pathology. Systemic therapy, if indicated, is typically reserved till after primary treatment of MESCC, but patients with chemoresponsive tumors may receive primary chemotherapy. The selected RT schedule should be personalized to each patient and commonly is 30 Gy in 10 fractions (fx), 20 Gy in 5 fx, or 8 Gy in 1 fx. MESCC recurrence may be treated with additional RT, if within the spinal cord tolerance, or surgery. Stereotactic body radiation therapy (SBRT) has been used for high grade MESCC in patients with relatively intact neurologic function at a few centers with a very robust infrastructure to support rapid initiation of treatment within a short period of time, but is generally not feasible for most clinical practices. SBRT may be advantageous for low grade MESCC, recurrence, or in the post-operative setting. Detection of MESCC prior to development of high-grade compression or deterioration of neurologic function may allow patients to benefit more from advanced therapies and improve prognosis. CONCLUSIONS: MESCC is a devastating condition; optimal treatment should be personalized to each patient and approached collaboratively by a multidisciplinary team.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord CompressionSpinal NeoplasmsRadiosurgeryHumansPrognosisDecompression, Surgical

Stichwörter der Autor:innen

Epidural compressiondecompressionmalignant epidural spinal cord compression (MESCC)palliative radiationstereotactic body radiation therapy (SBRT)

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • Department of Neurosurgery, University of Michigan, Ann Arbor, MI, USA.
  • Department of Neurological Surgery, University of Washington, Seattle, WA, USA.
  • Division of Medical Oncology, Fred Hutchinson Cancer Center/University of Washington, Seattle, WA, USA.
  • Department of Neurology, Alvord Brain Tumor Center/University of Washington, Seattle, WA, USA.
  • Department of Radiation Oncology, National University Cancer Institute of Singapore, Singapore, Singapore.

Zitieren

APA

Zaki, P., Barbour, A., Zaki, M. M., Tseng, Y. D., Amin, A. G., Venur, V., McGranahan, T., Vellayappan, B., Palmer, J. D., Chao, S. T., Yang, J. T., Foote, M., Redmond, K. J., Chang, E. L., Sahgal, A., Lo, S. S., & Schaub, S. K. (2023). Emergent radiotherapy for spinal cord compression/impingement—a narrative review. Annals of Palliative Medicine. https://doi.org/10.21037/apm-23-342

Vancouver

Zaki P, Barbour A, Zaki MM, Tseng YD, Amin AG, Venur V, et al. Emergent radiotherapy for spinal cord compression/impingement—a narrative review. Annals of Palliative Medicine. 2023. doi:10.21037/apm-23-342

BibTeX
@article{Zaki2023,
  author = {Zaki, Peter and Barbour, Andrew and Zaki, Mark M and Tseng, Yolanda D and Amin, Anubhav G and Venur, Vyshak and McGranahan, Tresa and Vellayappan, Balamurugan and Palmer, Joshua D and Chao, Samuel T and Yang, Jonathan T and Foote, Matthew and Redmond, Kristin J and Chang, Eric L and Sahgal, Arjun and Lo, Simon S and Schaub, Stephanie K},
  title = {Emergent radiotherapy for spinal cord compression/impingement—a narrative review},
  journal = {Annals of Palliative Medicine},
  year = {2023},
  doi = {10.21037/apm-23-342}
}
Kostenlos starten →